Drug Profile
Zoniclezole
Alternative Names: CGS 18416; CGS 18416ALatest Information Update: 10 Feb 1997
Price :
$50
*
At a glance
- Originator Novartis
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 10 Feb 1997 No-Development-Reported for Epilepsy in Switzerland (Unknown route)